Page last updated: 2024-11-02

pioglitazone and Mitral Valve Insufficiency

pioglitazone has been researched along with Mitral Valve Insufficiency in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Mitral Valve Insufficiency: Backflow of blood from the LEFT VENTRICLE into the LEFT ATRIUM due to imperfect closure of the MITRAL VALVE. This can lead to mitral valve regurgitation.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dorkhan, M1
Dencker, M1
Frid, A1

Other Studies

1 other study available for pioglitazone and Mitral Valve Insufficiency

ArticleYear
Treatment with pioglitazone induced significant, reversible mitral regurgitation.
    Cardiovascular diabetology, 2008, Apr-30, Volume: 7

    Topics: Diabetes Mellitus, Type 2; Echocardiography; Humans; Hypoglycemic Agents; Male; Middle Aged; Mitral

2008